Dialysis Market | Global Growing Industry Key Players- Fresenius Medical Care AG & Co. KGaA, Baxter International, Inc., DaVita Inc., Nipro Corporation, B. Braun Avitum AG, Diaverum Deutschland GmbH., Nikkiso Co. Ltd.

Global Dialysis Market was valued at $86,621 million in 2016, and is estimated to reach $118,512 million by 2023, registering a CAGR of 4.5% from 2017 to 2023. The impact of the driving factors is expected to surpass the effect of restraints. Moreover, the technological advancements leading to higher adoption rate and untapped markets in the developing countries are expected to provide new avenues for the growth of dialysis market in the near future.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/374?utm_source=OPR

The function of the kidney is to remove waste products and excess fluid from the blood. This process is carried out with the help of dialysis when the kidney is not functioning properly. Waste products, such as urea and creatinine, are removed from the blood with the help of artificial and natural semipermeable membranes. In hemodialysis, the blood is purified using an artificial membrane, whereas, in peritoneal dialysis, the waste products are removed using peritoneum in abdomen, which acts as a natural semi-permeable membrane.

The major driving factors for the growth of dialysis market are increase in number of end-stage renal diseases, rise in incidence of diabetes and hypertension, and surge in funding for development of new products. In addition, growth in healthcare expenditure, rise in aged population, and increase in disposable income are expected to boost the market growth. Moreover, owing to lack of matching donors, dialysis treatment is given more preference over kidney transplant, which is expected to further fuel the market growth. However, lack of awareness about kidney diseases, product recall, and reduction in reimbursements for dialysis are expected to hamper the market growth.

The hemodialysis segment is the largest contributor toward the market growth. The peritoneal dialysis segment is anticipated to be a lucrative market due to the growth in demand for dialysis services for the treatment of neonates and children.

The services segment was the highest contributor toward the market growth in 2016, and is expected to maintain its dominance during the forecast period. This is attributable to the increase in the number of treatment centers and advancement of home-based services.

Get Customized Report @ https://www.alliedmarketresearch.com/request-for-customization/374?utm_source=OPR

In 2016, North America accounted for maximum contribution to the total revenue generated, owing to the high prevalence rate of diabetes and hypertension, presence of high disposable income, and high adoption rate of technologically advanced products. In addition, the presence of large number of dialysis centers in this region and rise in number of patients with chronic renal & kidney diseases are expected to boost the market growth. However, Asia-Pacific is expected to witness the highest CAGR during the analysis period, attributable to rise in incidence rate of kidney failure, low rate of organ transplantation, and rise in healthcare expenditure.

The key companies profiled in the report include Fresenius Medical Care AG & Co. KGaA, Baxter International, Inc., DaVita Inc., Nipro Corporation, B. Braun Avitum AG, Diaverum Deutschland GmbH., Nikkiso Co. Ltd., NxStage Medical, Inc., Asahi Kasei Corporation, and Medicators, Inc.

LIST OF FIGURES

FIGURE 1. SEGMENTATION OF GLOBAL DIALYSIS MARKET
FIGURE 2. TOP INVESTMENT POCKETS IN GLOBAL DIALYSIS MARKET
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, 2014-2017
FIGURE 4. BARGAINING POWER OF BUYERS
FIGURE 5. BARGAINING POWER OF SUPPLIERS
FIGURE 6. THREAT OF NEW ENTRANTS
FIGURE 7. THREAT OF SUBSTITUTION
FIGURE 8. COMPETITIVE RIVALRY
FIGURE 9. RESTRAINTS AND DRIVERS: DIALYSIS MARKET
FIGURE 10. DIALYSIS MARKET: SEGMENTATION, BY TYPE
FIGURE 11. DIALYSIS MARKET: SEGMENTATION, BY PRODUCTS AND SERVICES
FIGURE 12. DIALYSIS MARKET: SEGMENTATION, BY END-USERS
FIGURE 13. U.S.: DIALYSIS MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 14. MEXICO: DIALYSIS MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 15. CANADA: DIALYSIS MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 16. GERMANY: DIALYSIS MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 17. FRANCE: DIALYSIS MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 18. UK: DIALYSIS MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 19. ITALY: DIALYSIS MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 20. SPAIN: DIALYSIS MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 21. REST OF EUROPE: DIALYSIS MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 22. JAPAN: DIALYSIS MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 23. CHINA: DIALYSIS MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 24. AUSTRALIA: DIALYSIS MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 25. INDIA: DIALYSIS MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 26. SOUTH KOREA: DIALYSIS MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 27. TAIWAN DIALYSIS MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 28. REST OF ASIA-PACIFIC: DIALYSIS MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 29. BRAZIL: DIALYSIS MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 30. SOUTH AFRICA: DIALYSIS MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 31. SAUDI ARABIA: DIALYSIS MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 32. REST OF LAMEA: DIALYSIS MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 33. ASAHI KASEI: NET SALES, 2014-2016 ($MILLION)
FIGURE 34. ASAHI KASEI: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 35. ASAHI KASEI: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 36. B BRAUN: NET SALES, 2014-2016 ($MILLION)
FIGURE 37. B BRAUN: REVENUE BY SEGMENTS, 2016 (%)
FIGURE 38. B BRAUN: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 39. BAXTER: NET SALES, 2014-2016 ($MILLION)
FIGURE 40. BAXTER: REVENUE BY PRODUCT, 2016 (%)
FIGURE 41. BAXTER: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 42. DAVITA: NET SALES, 2014-2016 ($MILLION)
FIGURE 43. DAVITA: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 44. DIAVERUM: NET SALES, 2015-2016 ($MILLION)
FIGURE 45. FRESENIUS MEDICAL CARE: NET SALES, 2014-2016 ($MILLION)
FIGURE 46. FRESENIUS MEDICAL CARE: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 47. FRESENIUS MEDICAL CARE: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 48. NIKKISO: NET SALES, 2014-2016 ($MILLION)
FIGURE 49. NIKKISO: REVENUE SHARE BY SEGMENTS, 2016 (%)
FIGURE 50. NIKKISO: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 51. NIPRO: NET SALES, 2014-2016 ($MILLION)
FIGURE 52. NIPRO: REVENUE SHARE BY PRODUCT, 2016 (%)
FIGURE 53. NIPRO: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 54. NXSTAGE: NET SALES, 2014-2016 ($MILLION)
FIGURE 55. NXSTAGE: REVENUE SHARE BY SEGMENTS, 2016 (%)

Access Full Summery @ https://www.alliedmarketresearch.com/press-release/dialysis-market.html

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.